BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Bedfont Scientific Continue To Sell To The U.S.A. Business As Usual

  April 6, 2016

   · 

  1 min read
• SynbiCITE Release: UK’s First Commercial Synthetic Biology Foundry Goes Into Production

  April 6, 2016

   · 

  1 min read
• Catalyst Communications Wins UK Innovation & Excellence In Technology-Focused Communication Services Award

  April 6, 2016

   · 

  1 min read
• Policy

  Ortho Kinematics Becomes ISO 13485-Certified And Clears FDA Audit

  April 6, 2016

   · 

  2 min read
• BioCapital

  Lonza Group To Highlight A New 3D Culture System Reforming Spheroid Culture And Analysis At AACR 2016

  April 6, 2016

   · 

  4 min read
• Policy

  Mevion Medical Systems Brings Proton Therapy To Central Florida

  April 6, 2016

   · 

  3 min read
• BioMidwest

  SurModics Announces First Patient Enrolled In IDE Study Of Surveil Drug-Coated Balloon

  April 6, 2016

   · 

  6 min read
• FDA

  Omixon Release: Holotype HLA Now CE-IVD In Europe

  April 6, 2016

   · 

  3 min read
• FDA

  European Commission (EC) Approves Bristol-Myers Squibb’s Opdivo (Nivolumab) For Previously Treated Advanced Renal Cell Carcinoma

  April 6, 2016

   · 

  16 min read
• FDA

  European Commission (EC) Approves Expanded Use Of Bristol-Myers Squibb’s Opdivo (Nivolumab) To Include Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

  April 6, 2016

   · 

  18 min read